REVIEW ON MICRONEEDLE DRUG DELIVERY SYSTEM
Transcript of REVIEW ON MICRONEEDLE DRUG DELIVERY SYSTEM
www.wjpps.com │ Vol 9, Issue 11, 2020. │ ISO 9001:2015 Certified Journal │
2643
Patel et al. World Journal of Pharmacy and Pharmaceutical Sciences
REVIEW ON MICRONEEDLE DRUG DELIVERY SYSTEM
Smit Patel1*, Jitendra Patel
2 and Umesh Upadhayay
3
1Student
Sigma Institute of Pharmacy, Bakrol, Vadodara, Gujarat 390019, India.
2Associate Professor Sigma Institute of Pharmacy, Bakrol, Vadodara, Gujarat 390019, India.
3Principal
Sigma Institute of Pharmacy, Bakrol, Vadodara, Gujarat 390019, India.
ABSTRACT
Microneedle is the one of the best-targeted drug delivery system.
Microneedles has several types one of the micro syringes,
Microneedles patches, Admin Pen, derma roller etc. Microneedles
have been fabricated with a range of sizes, shapes and materials. Most
drug delivery studies have emphasized on solid microneedles, which
have been shown to increase skin permeability to a broad range of
molecules and nanoparticles in-vitro. In vivo studies have
demonstrated delivery of oligonucleotides, reduction of blood glucose
level by insulin and induction of immune responses from protein and
DNA vaccines.
KEYWORDS: Microneedle, Microneedle classification, Microneedle patches, Microneedle
pen & roller.
INTRODUCTION
The Microneedles drug delivery system is one of the impactful methods of the transdermal
drug delivery system. The transdermal drug delivery system (TDDS) is a deliver drug
substance via the skin. Specifically, the skin is one of the best targets for drug delivery
because in our body all organs are surrounds by the blood.[1]
The microneedle technology to
the increase delivery of high molecular weight drugs through the skin. It is the concept of the
combine the patches and hypodermic injections.[2]
The microneedle drug delivery system has
enhanced the popularity in the pharmaceutical industry in now days.[3]
This system is painless
and causes of this benefit it is the delivering drugs and vaccines through the membrane.[4]
The
microneedle size ranges from 1-100 microns in length and 1 micron in diameter. These are
WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
SJIF Impact Factor 7.632
Volume 9, Issue 11, 2643-2672 Review Article ISSN 2278 – 4357
*Corresponding Author
Smit Patel
Student Sigma Institute of
Pharmacy, Bakrol,
Vadodara, Gujarat 390019,
India.
Article Received on
22 Sept. 2020,
Revised on 12 October 2020,
Accepted on 02 Nov. 2020
DOI: 10.20959/wjpps202011-17776
www.wjpps.com │ Vol 9, Issue 11, 2020. │ ISO 9001:2015 Certified Journal │
2644
Patel et al. World Journal of Pharmacy and Pharmaceutical Sciences
defined as micro-scale needles, arranged on a transdermal patch. Microneedles are currently
being utilized to enhance transdermal delivery of small and large molecules.[5]
For the proper effect of the drug, it need to the cross barrier of the tissue. In this situation, the
barrier is the skin‟s outer membrane of the stratum corneum. It just 10µm-20µm in thickness.
Moreover, microneedle is easily passing this layer by the passively diffusing.[6]
Viable
epidermis pass located below the stratum corneum, 50 µm-100µm and dermis layer1mm-
2mm. below the epidermis located blood vessels, nerves, hair follicles and sweat glands.[7]
Figure 1: Cross section through human skin (A) intracellular, (B) hair follicles and
sweat glands, (C) Direct pathway through the SC and, (D) depicts the micron-sized
holes that can be created by MNs upon the skin.[8]
Microneedles required for constructing microneedles includes glass, silicone, metal such as
stainless steel, solid or coat of gold over nickel, palladium, cobalt and platinum and
biodegradable polymers. Microneedles designing as to minimize the pain and some specific
microneedles are also painless.[9]
Microneedles device is made by the arranging so many microneedles in array on the tiny
patch in order to sufficient drug on the patch for the therapeutic responses and this
hypodermic needle piercing into the upper layer of the skin (stratum corneum). Numerous
studies have found a marked increase in drug transport through the skin when using
microneedle arrays alone, in combination with other enhancers or even when including more
sophisticated devices such has micropumps.[10]
www.wjpps.com │ Vol 9, Issue 11, 2020. │ ISO 9001:2015 Certified Journal │
2645
Patel et al. World Journal of Pharmacy and Pharmaceutical Sciences
According to the present invention of the microneedle drug delivery system used for delivery
of a solid or gel-type drug by forming a solid or gel-type drug. Layer on the top Surface of
capsule-disrupting micro-projections or on the bottom surface of the microneedles for
piercing the skin, and filling a solvent capable of dissolving the drug in the drug-containing
capsule .When the microneedle piercing to the skin and filling a solvent dissolve the drug into
the capsule. When the capsule disturbed that time solvent flow out from the capsule and gel
type drug contained into the drug layer so drug is dissolve in the body. Moreover, this time
microneedles tip protection film for preventing separation of drug.[11]
Microneedle has proved that it is very worth it in the many fields in the pharmaceutical
industry. It is used in the cancer therapy, biomedical sensors and sample collection, and used
in the delivery of the vaccine in the human. It is continence the combination of the MN and
CS would be conductive to develop the novel patch with the function of smart drug delivery
for promoting would heal.[12]
Microneedles Pre-treatment of the skin with MN resulted in
increased transdermal flux of the beta-blockers as compared with the Passive delivery. The
flux values resulting from MNs pre-treatment are 6-fold to 10-fold higher than that of
corresponding Passive diffusion.[13]
We have demonstrated that these microneedles not only showed excellent adhesion when
applied to knuckles and ideal antibacterial activity but also performed well in drug-sustained
release and treatment for the osteoarthritis rat model. These results indicate that bio inspired
multifunctional microneedles will break through the limitation of traditional methods and be
ideal candidates for versatile transdermal drug delivery systems.[14]
Microneedle drug delivery technology
Microneedlling first used in the 1995 by Dr. Desmond Fernandez in Philadelphia to treat for
the wrinkles with help of the hypodermic needles. However, the first proof of the concept of
this technique emerged in 1998 by Henry et al.[15]
The microneedle ranges in size, shape and
microneedle range in size, shape, and function but are all used as an alternative to other
delivery methods like the conventional hypodermic needle or other injection apparatus.
Microneedle system can be apply on the patches, pen-shaped instruments, roller, stamps,
conventional syringes, or prefilled syringes since 1995. Microneedle technology first used in
the treatment of the acne, after used in the aesthetics products, also used in the delivery of the
specific drugs, vaccines, small-molecules drugs, so on.[16]
www.wjpps.com │ Vol 9, Issue 11, 2020. │ ISO 9001:2015 Certified Journal │
2646
Patel et al. World Journal of Pharmacy and Pharmaceutical Sciences
Nowadays, transdermal drug delivery used for the patient compliance therapies. This therapy
also in the demand because there are many benefits from this technique as compare to the
conventional methods. Protein as a drug its major role in the treatment of the cancer,
vaccination, genetic disorders, inflammation, etc. but delivery of the protein through the
transdermal conventional methods it is difficult to pass through the stratum corneum. So
overcome to this problem used the microneedle system and it does easily penetrate through
the stratum corneum. Moreover, the use of microneedle likewise brings many benefits over
the cancer therapy and its easily controllability and applicability.[17]
Ranges of miniaturized needles are used to penetrate the skin layer. Since the needles are
short, they do not reach the nerve-rich regions of the lower parts of the skin. When the
microneedles are piercing into the skin. They are shorter penetrate and do not reach the
nerve- rich regional of the lower part of the skin.
By using batch-fabrication methods from the microelectronics industry, small-scale
microneedles can be mass-produced with high accuracy and reproducibility in an economical
manner.[18]
Excellent future of the Microneedle drug delivery system
Good efficacy and safety.
Painless drug delivery system.
Rapid onset of action.
Good stability.
Improve patient compliance.
Self-injectable.
Cost effective.[19]
Now days, biotechnology has produce many more potent drugs. There are so many methods
for the delivery these drugs into the body. However, there are such limitations.[20]
Like as oral
drug delivery for the DNA based, protein based and other therapeutic substance is generally
not possible to degradation of the drug by the gastrointestinal tract or elimination by the liver.
So used the anther technique by the injection, its direct to the blood stream or intramuscular
and subcutaneous injection. Nevertheless, this method has some limitation like pain, trauma
caused by the needle, need to expert for the drug delivery, and do not provide sustained
released drug delivery.
www.wjpps.com │ Vol 9, Issue 11, 2020. │ ISO 9001:2015 Certified Journal │
2647
Patel et al. World Journal of Pharmacy and Pharmaceutical Sciences
To overthrow from this problem used the microneedle system. Which provide the sustained
release of the drug and it is design by such that way it decreases the size of the needles, also
reduce the pain and trauma from the needles.[21]
Microneedle drug delivery technique first fabricated by the Han et al. First, microneedles
were fabricating inclined UV lithography and electroforming with sharp tip and low force to
insert into the body. It is enough long to penetration to depth. It is also control the shape, side,
length and sharpness of the tip.[22]
Advantages of microneedles
Microneedles system useful for the sustained release of the drug delivery system.
It is main advantage of microneedles over the normal needles, when normal needles
inserted into the skin, needles pass stratum corneum layer(which is the outer layer 10-
20μm of the skin) for the drug delivery it is effective but it cause the pain and some
infection and injury related to the Skin. However, when microneedle insert into the skin it
does not pass the stratum corneum layer. Therefore, this needle reduces the chances of
pain, infection, or any injury.[23]
Microneedles system has a rapid one set of action on the delivery site.
Very small microneedle could provide highly targeted drug administration to the
individual cells.
Immunization programs in developing countries, or mass vaccination or administration of
antidotes in bioterrorism incidents, could be applied with minimal medical training.[24]
Hollow like microneedle, solid increase permeability by inserting into the holes in skin,
rub drug over the area, or coating needles with drug.[25]
Microneedles fabricating by the silicone substrate because of that small size, thousands of
needles can be fabricated on the single patch. This lead to the high accuracy, good
reproducibility and low costing of fabrication.[26]
Array of hollow needles could be used to continue carry drugs into the body and used
pump for the diffusion of drug.[27]
Hollow microneedles could be used the remove body fluid such as blood glucose
measurements and then supply micro litre volumes of insulin or other drug as required.
• Avoidance of „first-pass‟ metabolism of drugs and providing a large surface area and ease
of accessibility for drug administration.
• Peak plasma levels of drugs are reduced, leading to decreased side effects.
www.wjpps.com │ Vol 9, Issue 11, 2020. │ ISO 9001:2015 Certified Journal │
2648
Patel et al. World Journal of Pharmacy and Pharmaceutical Sciences
• Reduction of fluctuations in plasma levels of drugs.
• Utilization of drug candidates with short half-life and low therapeutic index.[28]
Disadvantages of microneedles
The drug and other excipient may produce local irritation, itching, and oedema, which is
present in the patch.
Limited permeability across through the skin may limit the delivery of number of
drugs.[29]
Microneedles are used in various instruments like as conventional syringes, microneedles
patches, pen-shaped instruments, rollers, stamps, or prefilled syringes since 1995, first time
microneedles were used for the treatment of the acne scars.[30]
Micro syringes used for the treatment for the conventional drug delivery system. When
microneedles patches used in the treatment for the alopecia and transdermal disease. And
roller were used for the cosmetic products improve the skin appearance.
Classification of microneedle
The most common material used for micro fabrication on the needles by the silicone. These
microneedles have extremely sharp tips that facilated easily piercing of the membrane.[19]
Microneedle can be divided into four categories like solid, coated, hollow, polymer.
1) Hollow microneedles
- Hollow microneedles presented by the McAllister et al. in 1999 and 150μm long hollow
microneedles and micro tubes could be fabricated.[18]
Figure 2: Hollow microneedle “poke and flow” approach.[31]
www.wjpps.com │ Vol 9, Issue 11, 2020. │ ISO 9001:2015 Certified Journal │
2649
Patel et al. World Journal of Pharmacy and Pharmaceutical Sciences
- Hollow microneedles system has been most successful in terms of commercialization. It
is used for the one time used injection of the drugs. However, if the needles attached to
the skin for a long period, congestion is a possible problem that to be stunned, and access
blood.[32]
- Hollow microneedles are like regular hypodermic needles but shorter in length. In this
type, liquid formulation of the drug is infused through bores in the microneedles. This
advance is more evocative of an injection than a patch.[19]
- Hollow microneedles contain a hollow bore in the centre of the needle hollow
microneedles can also be used for the large drug contained.
- Hollow microneedles can be penetrate into the viable epidermis to dermis avoiding the
stratum corneum
- Silicon microneedles of 300 μm in height, with 130 μm outer diameter and 110 μm inner
diameter at the tip
- These are very expensive to prepare and require expensive micro fabrication techniques.
- Hollow microneedles use especially for the vaccines, proteins likes as high molecular
weight compounds.[29]
- Hollow microneedles more valuable method for its controlled drug release feature.
- It is less used due to its practical problems.
- Most studies on hollow microneedles were of in experimental performance.[33]
2) Solid microneedles
Figure 3: Solid microneedle “poke with patch” approach.[31]
- Solid microneedles are the first type of the microneedles drug delivery. The Diazon et al
developed it in 1993.
www.wjpps.com │ Vol 9, Issue 11, 2020. │ ISO 9001:2015 Certified Journal │
2650
Patel et al. World Journal of Pharmacy and Pharmaceutical Sciences
- The microneedles were successful inserted into the skin and its dissolve at 0, 60, 120 and
180 s after the inserted.
- Solid microneedles fabricated from silicon, metal and polymer.
- Fabricated solid microneedles with rectangular cup shaped tip are 200 μm in height.
- The cup shaped tips have dimensions of 60 × 60 μm (length × breadth) with a depth of 60
μm.
- The cup is filled with the drug using the novel drug coating methods.
- Solid microneedles is passed out by the passive diffusion for drug deliver by creating
micro channels to enhance skin permeability followed by the application of a drug-loaded
patch on the channels.
- Solid microneedles can be fabricated by the polymer. It prepared from the biopolymers
film extracted from the fish scales of tilapia.[34]
- Solid microneedles piercing an array of solid microneedles into the membrane followed
by application of the drug patch at the treat site. Transport of drug transversely skin can
occur by diffusion or ionotophoresis if an electrical field is applied.[35]
- Solid microneedles can be used to create holes in the skin through which is more easily
transport of the drug.
- These microneedles were inserted into tissue it enhance molecular uptake and gene
transfection. After that developed for the transdermal delivery application, which is
inserted into the skin and it deliver in vitro and in vivo.[36]
3) Coated microneedles
- This type of the needle is coated with the drug substances. Then inserted into the skin for
the dissolution. Entire drug is the dissolve by itself.
- Coated needles method used the dip and rub approach for the delivered of the drug
substance. Where a microneedle are first dipped into a drug solution and then enter the
drug into the skin and after drug is apply then its leave within the micro abrasions twisted
by the needles.[19]
www.wjpps.com │ Vol 9, Issue 11, 2020. │ ISO 9001:2015 Certified Journal │
2651
Patel et al. World Journal of Pharmacy and Pharmaceutical Sciences
Figure 4: Coated microneedle “coat and poke” approach.[31]
- A plethora of methods has been used in the literature to prepare coated microneedles
advantages of hydrogel-forming microneedles are that they can be fabricated in a wide
range of patch sizes and geometries, can be easily sterilized, resist hole closure while in
place and are removed completely intact from the skin.[37]
- Coated polymer is stick on the microneedles. Because of their structural and storages
advantages and delivery of such microneedles is diffusion through the skin.[38]
4) Polymers
- Microneedles are made of the polymers. Polymers that can be dissolving, non-dissolving
or hydrogel- forming.[29]
Dissolving microneedles
- This type of microneedles is encapsulation with the drugs, this type microneedles are
insertion into the skin for controlled drug release.[19]
- Dissolving microneedles have to many of advantages. These include the one-step
application process, which is convenient for patients.
- Dissolving microneedles are fabricated based on the “poke and release” principle. They
aremade from polysaccharides or other polymers. These microneedles release
encapsulated drug into the skin following application and dissolution.
- Micro moulding is the preferred fabrication method for making dissolving microneedles.
- Certain drugs and vaccines are thermo labile so moulds are sometimes filled with
solutions of drugs and excipients and then dried under minor situations.
- The manufacture process involves pouring the polymer solution into female molds, filling
the micro cavities of the mould under vacuum or pressure, drying under ambient
www.wjpps.com │ Vol 9, Issue 11, 2020. │ ISO 9001:2015 Certified Journal │
2652
Patel et al. World Journal of Pharmacy and Pharmaceutical Sciences
conditions, centrifugation or pressure. Master structures for microneedles supporting
arrays, and Chen et al. using proprietary electro-discharge-machining technology created
pressing tools. Each master structure consisted of 64 (8×8) microstructures.[39]
- Maltose has been tried for formation of biodegradable microneedles.[40]
Hydrogel – Forming microneedles
- Hydrogel-forming microneedle systems are relatively novel and were first developed by
Donnelly et al., in 2012. As with dissolving microneedle systems, mechanical strength
and physical stability are the main concerns associated with this system.
- Hydrogel-forming microneedles require materials that are strong enough for insertion into
the skin followed by rapid swelling and release of the drug after mixing with interstitial
fluids.
- Unlike dissolving microneedles, hydrogel-forming microneedle systems do not leave
microneedles in the skin, which represents a significant advantage.
- Another advantage is that dose limitation is less of a problem for these microneedles
compared to dissolving.
- Coated microneedles because hydrogel-forming microneedle systems use a drug
reservoir. So it is the also used as sustained release delivery.[16]
Figure 5: Hydrogel microneedle “poke and release” approach.[31]
www.wjpps.com │ Vol 9, Issue 11, 2020. │ ISO 9001:2015 Certified Journal │
2653
Patel et al. World Journal of Pharmacy and Pharmaceutical Sciences
Figure 6: Different types of microneedle (1) Solid MNs; (2) coated MNs; (3) dissolving
MNs; (4) hollow MNs and (5) hydrogel forming MNs.[15]
Recent patent of microneedles
Microneedle application is an emerging technique for transdermal drug delivery and the large
number of patent applications filed reflects this. The majority of these patent applications are
focused around design of, and delivery through, hollow microneedles since a higher amount
of drug can be delivered from such microneedles as compared with other microneedles. Many
of the patents based on hollow microneedle technology are also because of its major merit of
administration of a larger volume compared with other microneedles. So hollow microneedle
have more patent than the other microneedles.[41]
Figure 7: Division of patents filed based on type of microneedles.[42]
www.wjpps.com │ Vol 9, Issue 11, 2020. │ ISO 9001:2015 Certified Journal │
2654
Patel et al. World Journal of Pharmacy and Pharmaceutical Sciences
Different types of microneedles design variable
There are eight design variables to be manipulated and enhanced. The variables involved are
the shape of microneedle, the material used, and the array of the needles, microneedle base,
lumen base, and height of microneedle, height of lumen and height of the drug
container/reservoir. These variables are manipulated to achieve the required microneedle
specification as shown in Table 2. Figure 2 shows four types of microneedles shape involved
in this study, which are: a) canonical; b) pyramidal; c) hexagonal; and d) octagonal
Figure 8: Four Types of Microneedles Shape: (a) Canonical, (b) Pyramidal, (c)
Hexagonal, and (d) Octagonal.[43]
Despite the eight design variables to be optimized, there are two constant Variables in this
study. The constant variables are the pressure applied at the tip of microneedle and the size of
the microneedle array base. In this study, the pressure is set to 3.18 MPa because according
to, human skin offers resistance of 3.18 MPa during microneedle penetration. Hence, to
overcome This skin resistance, the microneedle must withstand the load more than 3.18 MPa.
As for the size of the microneedle array base, it is set to 5000 μm × 5000 μm × 50 μm.[44]
Microneedle patches (MNPs)
Microneedles patches made of the so many tiny needles are stuck on the one patch are called
as a microneedles patches. Microneedles patches have been fabricating to penetrate into the
stratum corneum with the micro-scale pores that are large enough to enable drugs, and small
molecules. When the apply the patches on the skin do not rub the patch. In addition, leave for
at least two hours, although it is best to leave it overnight for the better result.[45]
Microneedles are combined with drugs and make patch-like structure, a system can be
realized which essentially has all the favourable properties of a traditional transdermal patch,
either is continuous release, ease-of-use, unobtrusiveness and painlessness.
www.wjpps.com │ Vol 9, Issue 11, 2020. │ ISO 9001:2015 Certified Journal │
2655
Patel et al. World Journal of Pharmacy and Pharmaceutical Sciences
Different the standard patch, a microneedle-based patch allows delivery of almost any
macromolecular drug including insulin and vaccine. Such a patch would not only offer a
discreet and patient-friendly drug administration system, but also an efficient and possibly
safe way to administer drugs with minimum involvement from health-care professionals. And
over the 500 companies are start the start-up of the microneedle related transdermal drug
delivery system.[18]
Microneedles patches have so many advantages like it is avoid pain, irritation, and needle
phobia when the penetrate into the skin layer. Usually contain range of area approximately 1
cm2. Microneedles length generally between the 100-1000 μm.
Microneedles is made of two type of the substances.
[1] Non-water soluble material. [2] Water soluble material.
1) Non-water soluble material is made of the metal, polymer, or ceramic and some type
coated with drug formulation. These types of material not easily dissolve into the skin.
2) Water soluble material made of the saccharides or soluble polymers and encapsulated
with soluble material drugs.
Advatages of microneedle patches
Microneedle patches had big advantages is they avoid the first pass metabolism by the
targeted delivery to the dermal capillaries. Therefore, this is rapid onset of drug delivery
action.
Its grate advantages is that its self-administration therapy. This therapy not need expert
for the applying patches.
MNPs for cosmetics by this time been commercialized so many products sold for the
improving skin appearance. Moreover, many companies all around the world. The many
cosmetic MNPs presented commercially show that MNPs can be widely accepted in
many countries and cultures, and self-administered repeatedly in a home setting.
Even, Prepared MNPs for the onset action of migraine, they administration zolmitriptan
and its currently reached under the phase 3 clinical trials, it is give the peak drug
concentration and its six time higher on set action compared to the oral doses forms.
This method is most effective than the other transdermal drug delivery system.[46]
www.wjpps.com │ Vol 9, Issue 11, 2020. │ ISO 9001:2015 Certified Journal │
2656
Patel et al. World Journal of Pharmacy and Pharmaceutical Sciences
Figure 9: Microneedle patch (MNP) for transdermal drug delivery. (A) Representative
MNP. (B) Magnified view of microneedles. (C) Image showing skin histology after
puncture with a microneedle.[45]
This method is most effective for the treatment of alopecia (In the alopecia patient suffering
from the hair follicle problem). Studied the result of microneedle pre-treatment of the skin of
the scalp on hair growth in human subjects by comparing minoxidil treatment with or without
microneedling.
The microneedle treated group showed a expressively quicker speed of hair growth,
suggesting that microneedle pre-treatment improved the permeation of minoxidil drug
through the skin to the hair follicle, though the effect of microneedles on the drug transport
Process was not directly measured.[47]
We have established that these microneedles not only presented admirable adhesion when
applied to knuckles and perfect antibacterial activity but also accomplished good in drug-
sustained release and treatment for the osteoarthritis rat model.
These results indicate that bio inspired multifunctional microneedles will break through the
limitation of traditional methods and be ideal candidates for useful transdermal drug delivery
systems.
www.wjpps.com │ Vol 9, Issue 11, 2020. │ ISO 9001:2015 Certified Journal │
2657
Patel et al. World Journal of Pharmacy and Pharmaceutical Sciences
Figure 10: Diagram and digital images of the bio inspired multifunctional MNs
adhering to the knuckle of the thumb when the knuckle is bent to 90°. The thickness of
the MNs was 2 mm. The scale bar is 1.5 cm.[48]
Advance drug delivery system
1. Admin pen
Admin patch microneedle array if refined microneedle technology. Adminpen was developed
for the novel drug delivery system. In this technique, inject the microneedle array based pen-
injector that is painless and conveniently inject standardise drug into the skin. While enter the
medicine into the body this technology enhanced the efficacy, safety, and patient compliance.
This system is painless and instantaneously forms hundreds of small microspores through the
stratum corneum and epidermis. When the microneedle array is removed from the skin, the
microspores simply collapse, and the skin barrier is quickly restored
This device very economical and produce the large scale using the high volume low cost
process. Admin pen can inject the various vaccines like as a HIV, cancer, smallpox and give
hormone and insulin injection from this method. This technique similarly beneficial for the
cosmetic preparations. The technology cans delivery pharmaceutical drugs in 10 to 60
seconds versus the 1 to 2 hours. These transdermal patches are used for the small molecules
under 500 Daltons.
Figure 11: Microneedle- based adminpentm pen-injector device.
www.wjpps.com │ Vol 9, Issue 11, 2020. │ ISO 9001:2015 Certified Journal │
2658
Patel et al. World Journal of Pharmacy and Pharmaceutical Sciences
The human skin has three separate layers: the outer layer (stratum corneum), having a
reported thickness of between 10 to 30 microns; the viable epidermis, containing sentinel
cells of the immune system; and the dermis, within which are capillaries and various trauma-
sensing receptors. The aqueous channels formed by the microneedles in the stratum corneum
using the AdminPatch system have a depth of about 100 to 1000 microns, enough to extend
through the viable epidermis into the dermis to reach blood vessels but shallow enough to
avoid most pain receptors. AdminMed has completed studies that show that while the
AdminPen microneedle devices are kept applied on the skin, the microspores formed by
microneedles allows injection of drug or any other liquid from an attached syringe into the
underlying skin.
Figure12: Adminpentm connected to a regular syringe filled with blue dye.
Advantages
Adminpen technology enhanced the patient compliance and this technique is painless
system as a compare to the other drug delivery system.
Admin pen can inject the various vaccines like as a HIV, cancer, smallpox and give
hormone and insulin injection from this method.
This technique compatible with the standard syringes and its precise modest system for
the using.
This pen tip is don‟t harm to the skin. And not produce the any hazardous side effects.
Admin pen technique attractive for the pharma companies because of the there low cost
and high speed manufacturing process.
Admin pen uniformly inserted into flexible skin.[49]
www.wjpps.com │ Vol 9, Issue 11, 2020. │ ISO 9001:2015 Certified Journal │
2659
Patel et al. World Journal of Pharmacy and Pharmaceutical Sciences
2. Derma pen and derma roller
Microneedling is an effective and valuable procedure that can be used to tighten, regenerate
and refresh the aged skin in natural way. This modality has proved it, can reverse the physical
as well as histopathological signs of aging, taken into account the easiness of its application
and free risk procedure with no lost time. This innovative technique of microneedling is very
revolutionary and considered a great breakthrough in microchanneling for beautification of
the skin, eluding pain and no lost time.
Ageing of the skin is a multifactorial incident, which circulates of the increasing effects of
chronic exposure to sun UV radiation, degradation and decline of elastin fibres, noticeable
collagen reduction incurring wrinkle progress, as well as development and profound digging
out.[50]
Figure 13: Derma pen.
Figure14: Derma roller.
www.wjpps.com │ Vol 9, Issue 11, 2020. │ ISO 9001:2015 Certified Journal │
2660
Patel et al. World Journal of Pharmacy and Pharmaceutical Sciences
It can be carried out by a simple relatively cheap method.
1) Derma pen an advanced automated electrical calibrated microneedling
2) Device derma roller or a slightly costly
3) Expensive comparatively the fractional controlled microtunneling laser.
Both tools are however simple to work, as they are remarkable hand held medical devices
which naturally increase the levels of collagen and elastin in the treated skin.
Application
It assists in minimizing the appearance of spots and surgical marks, post-burn mark, Post-
traumatic scar, hypertrophic scars, varicella marks.
Diminishing fine lines and wrinkles, uneven skin tone and pigmentation, minimize pores,
reduce sebum production, reducing skin imperfections and tightening the skin and
increasing firmness, minimizing stretch marks, and improving skin texture and increasing
blood supply to the skin along with hydration.
Microneedling also support in removing the scales and sebum residue around the hair
infundibulum.
The skin comprises a barrier to penetration of exogenous substances to the body, skin
and the hair.
In fact, they do provide advanced skin needling, which stimulates the skin to self-
regenerate and self-repair naturally and safely, promoting a smoother, brighter, radiant,
healthier younger-looking skin. These treatments are recommended in every month for
get the desirable results.[51-52]
All measurements were performed in a temperature-controlled room at 21 ± 1°C. All
participants were in a semi-supine position in a bed for at least 10 minutes before the
measurements started. All measurements were done on the forearms which were disinfected
with a skin cleaner (Klorhexidin 5 mg/ml, Fresenius Kabi AB, Uppsala, Sweden) before the
experiments. Stainless steel microneedles arrays wereused in all experiments. This
experiment devided into the two rows and need 8 microneedles. And used the 300 μm, 500
μm and 750 μm lengths.[53]
www.wjpps.com │ Vol 9, Issue 11, 2020. │ ISO 9001:2015 Certified Journal │
2661
Patel et al. World Journal of Pharmacy and Pharmaceutical Sciences
Table 1: Different types of microneedles products in the world.[54]
Fabrication of microneedle
For the making polymer microneedles for controlled-release, delivery involved fabricating
structures using the micro electrical system (MEMS) techniques. There are uses the mould
for the make microneedle shape, and used the biodegradable polymer for the making
microneedles. There are two different geometries of the microneedle structure fabricated by
the SU-8 epoxy using lithography-based methods.
Representative bevelled-tip microneedles are shown in Fig. A and have a base radius of 50
mm, a tip radius of 5 mm, and a height of 600 mm. The needles are positioned in a 20 _ 6
arrays with centre-to-centre spacing between needles of 400 and 1400 mm. The needle height
was controlled by the thickness of SU-8 photoresist casting and etching parameters. The tip
sharpness was controlled by the etching parameters.
www.wjpps.com │ Vol 9, Issue 11, 2020. │ ISO 9001:2015 Certified Journal │
2662
Patel et al. World Journal of Pharmacy and Pharmaceutical Sciences
Figure 15: Microscopy images of microneedles. (A) bevel-tip microneedles and (B)
tapered-cone microneedles used as master structures (imaged by SEM). (C) bevel-tip
and (D) tapered-cone microneedles made of PLGA and encapsulating calcein within
their tips. Using a double-encapsulation method produced microneedles that
encapsulate micro particles that, in turn, encapsulate calcein. (E) Cutting off the tip of a
PLGA microneedle reveals the PLA micro particles within (imaged by SEM). (F) A
complete 20*10 array of PLGA microneedles is shown.[55]
Fabrication of Inorganic Material MNs Since the first solid MNs made of silicon by reactive
ion etching was reported, the techniques to fabricate the silicon MNs have been developed for
years. This type of method use that the ceramic slurry was filled into the cavities of moulds,
and then the ceramic MNs were formed when the ceramic materials were dried. This method
required the clean room and this method is very expensive method.
Glass MNs are usually manufactured by pulling of glass rods using pipette puller. For
example, pipette puller to fabricate the glass MNs based on borosilicate glass capillary tubes.
The MNs with fine gradually tapered shape by pulling of borosilicate glass rods using a
micropipette puller. The MNs were cut into different finial length by platinum wire. After
that, the tips were fire polished until smooth and then the MNs were bent into a cantilever by
www.wjpps.com │ Vol 9, Issue 11, 2020. │ ISO 9001:2015 Certified Journal │
2663
Patel et al. World Journal of Pharmacy and Pharmaceutical Sciences
the micro forge. Micromolding process to fabricate BCMN-G. BCMN-G indicates bio
ceramic microneedle with gelatine substrate.[35]
Figure 16: Fabrication of microneedles.[57]
Microneedle use for treatment of diabetes mellitus
Normally we can classify into two types. (1) Insulin dependent diabetes, type 1 and (2)
Diabetes mellitus, type 2 diabetes. In the first type of diabetes treated by the giving insulin
and type 2 diabetes are treated by the metformin, sulfonylurea, etc.
(1) Insulin dependent diabetes
Insulin is one of the most challenging drug of all times for the drug delivery technology.
Insulin dependent diabetes first MNs developed by the Martanto et al. (2004) used MN arrays
(7 × 15) for transdermal delivery of insulin in diabetic rat models.
During and after MN treatment, an insulin solution (100 or 500 U/ml) was placed in contact
with skin for 4 hours.[45]
blood glucose level steadily decreased by as much as 80% with the
decrease in glucose level being dependent on the insulin concentration.[58]
These MNs is suitable for transdermal delivery of drugs with a relatively high degree of
water solubility, for example, metformin HCl. The primary objectives of this work included
formulating a well formed lyophilised drug reservoir using biocompatible materials with a
high drug loading of metformin HCl, rapidly dissolving in aqueous fluid and yielding high
drug recovery. This MN type and shows that hydrogel-forming MNs have considerable
promise for commercial success.
www.wjpps.com │ Vol 9, Issue 11, 2020. │ ISO 9001:2015 Certified Journal │
2664
Patel et al. World Journal of Pharmacy and Pharmaceutical Sciences
MNs should have sufficient mechanical strength and demonstrate consistent insertion
properties to achieve successful application of MN array into the dermatomed porcine skin in
vitro and rat skin in vivo.[59]
(2) Diabetes mellitus
This type of the diabetes is used microneedle patches for the treatment. Drugs are available to
treat type-II diabetes such as sulfonylurea, metformin, alpha-glycosidase inhibitor.
Figure 17: Preparation of single layer dissolving micro-needle.
Figure 18: Mechanism of action of metformin & glipizide through double-layered
microneedle.[60]
www.wjpps.com │ Vol 9, Issue 11, 2020. │ ISO 9001:2015 Certified Journal │
2665
Patel et al. World Journal of Pharmacy and Pharmaceutical Sciences
Microneedle vaccination
Most vaccines, such as polio, diphtheria, tetanus or pertussis, are administered in the first
year after birth and during childhood. Vaccination using a conventional needle system often
poses challenges for both parents and medical due to needle phobia and pain.
MNs can have a major positive impact on childhood vaccination as already demonstrated by
the positive perception from parents, children and medical staff.[61]
Children‟s skin is thinner
compared with adult skin and may require new and deeper studies on the pharmacodynamics
of transdermal drug dissolution. However, some studies have reported no deference in skin
thickness depending on age, gender or body mass index in children below 5 years old; and
although they found variable thicknesses in diverse areas of the body, these were found to
have no clinical relevance.
It is considered that children‟s top layer of skin can be disrupted with a needle height of
around 300 mm and a diameter of less than 100 mm. In terms of dosage, a lower dosage
requirement in paediatrics is expected, which may make it easier to achieve therapeutic doses
through MN patches. These parameters have to be addressed by designing suitable
microneedle architectures to target children of different age groups infants, children and
adolescents.[62]
MNA delivery has the potential to accelerate the process of vaccine production and to
significantly reduce cost by considerably reducing the required vaccine doses. The stability
studies with our MNA SARS-CoV-2 vaccines are currently in progress. However; there is
evidence in the literature that vaccine components including proteins are typically stabilized
by integration into the MNA polymer matrix, and retain their conformational structures, as
evidenced by maintenance of antibody binding function MNAs described here are designed
to be applied without the need for an applicator or any specialized equipment, supporting the
potential for self-administration. Combining emerging biotechnology methods with
bioengineering advances in vaccine delivery strategies, it may now be possible to rapidly
produce clinically translatable vaccines against novel pathogens for human testing and
subsequent global distribution in time to significantly impact the spread of disease.[63]
Clinical study of microneedle
There are a lot of studies of the microneedle transdermal drug delivery. And this delivery
used in both ex vivo and vitro. There is only few success studies report on the human. The
www.wjpps.com │ Vol 9, Issue 11, 2020. │ ISO 9001:2015 Certified Journal │
2666
Patel et al. World Journal of Pharmacy and Pharmaceutical Sciences
first reported human study was carried out by Kaushik et al. [64] consisting of 12 human
volunteers between the ages of 18-40 years to demonstrate the application of MN is a
painless procedure. The MN used in this experiment was 150 μm long with a base diameter
of 80 μm and tip radius of 1 μm. In this study used the pointed tip fir the microneedles.
First clinical trial of microneedle transdermal delivery on the human carried out by
Wermeling et al. they used 5 × 10 microneedle arrays with a height of 620 μm and a width of
160 μm was used in this study. And take the naltrexone compound as a sample. A blood
sample carried out from the upper arm over a period of time of 72 hr. and in the end this
volunteer do not shown sign of redness, edema. MN technology fabricated with
biocompatible material is safe, painless and offers exciting opportunities for transdermal
delivery compared to hypodermic needles.[65]
CONCLUSION
Microneedles also in the form of patch or syringe have been observed as a possible
transporter for the effective transdermal delivery for the delivery of numerous
macromolecular drugs. Various research reports studied confirmed that microneedles are
ought to be the prominent carriers for enhancing the permeation deep into the systemic
circulation and providing a painless, effective and safe route for the drug delivery. In future
microneedles plays important role in innovation and design of controlled drug delivery for
various drugs. These painless systems are slowly gaining importance and would qualify to be
one of the important devices for controlled drug release in future. Thus, it was concluded that,
these systems represented it to be an efficient and superior carriers as compared to other
needle based formulation for the transdermal delivery.
Future perspectives
Microneedles can be considered emerging devices in the field of drug delivery compared
with current other techniques. Microneedle is used for the vaccination in future. In fact, MNs
have achieved excellent results, especially in the cosmetic field, undergoing rapid growth in
the last decade. For example, the Raphas Company and many more currently sell
Microneedle patches around the world for cosmetic purposes. Moreover, multicompartmental
and novel smart materials, such as hydrogel MNs, can provide a designed drug release which,
in the case of bio responsive MNs, is even more advanced and effective. Starting from these
new proposals and developing progressively innovative technologies, microneedles could
represent a significant improvement in the fields of drug administration and delivery, disease
www.wjpps.com │ Vol 9, Issue 11, 2020. │ ISO 9001:2015 Certified Journal │
2667
Patel et al. World Journal of Pharmacy and Pharmaceutical Sciences
treatment, and cosmetic applications. of course, on an engineering level, the complexity of
the system needs to be justified by the final application, always respecting the market price
expectations. So we can say that microneedle technology is future of the drug delivery
approach.
REFERENCES
1. Chandrashekar NS, Shobha Rani RH. Physicochemical and pharmacokinetic parameters
in drug selection and loading for transdermal drug delivery. Indian J Pharm Sci, 2008; 70:
94-6.
2. Barrak Al-Qallaf a and Diganta Bhusan Dasb, "Optimizing Microneedle Arrays to
Increase Skin Permeability for Transdermal Drug Delivery ", Interdisciplinary Transport
Phenomena V: Ann. N.Y. Acad. doi: 10.1111/j.1749-6632.2009.04083.
3. R. K. Sivamani, D. Liepmann, H.I. Maibach, Microneedles and transdermal applications,
Expert Opin. Drug Deliv, 2007; 4: 19–25.
4. Y. C. Kim, J.H. Park, M.R. Prausnitz, Microneedles for drug and vaccine delivery,
Adv.Drug Deliv. Rev, 2012; 64: 1547–1568.
5. Gupta J., Gill H.S., Andrews S.N., Prausnitz M.R. Kinetics of skin resealing after
insertion of microneedles in human subjects. J. Control. Release, 2011;154:148–155. doi:
10.1016/j.jconrel.2011.05.021.
6. Devin V. McAllister, Mark G. Allen, and Mark R.Prausnitz1,
"MICROFABRICATEDMICRONEEDLES FOR GENE AND DRUG DELIVERY",
Annu. Rev. Biomed. Eng, 2000; 02: 289–313.
7. van der Maaden K, Jiskoot W, Bouwstra J. Microneedle technologies for (trans)dermal
drug and vaccine delivery. J Control Release, 2012; 161(2): 645–655.
8. Karmen Cheung & Diganta B. Das Microneedles for drug delivery: trends and progress,
Drug Delivery, 2016; 23: 7, 2338-2354. DOI: 10.3109/10717544.2014.986309. ISSN:
1071-7544.
9. NIDA AKHTAR," MICRONEEDLES: AN INNOVATIVE APPROACH TO
TRANSDERMAL DELIVERY- A REVIEW ", International Journal of Pharmacy and
Pharmaceutical Sciences, 2014; 6(4): ISSN- 0975-1491.
10. Nayak Smita, Suryawanshi Sanidhya, Vaidhun Bhaskar, "Microneedle technology for
transdermal drug delivery: application and combination with other enhancing technique",
Journal of drug delivery and therapeutics, 2016. Doi.org/10.22270/jddt.v6i5.1285.
11. Seung Seob Lee, Daejeon, Boo Joon Sul, Man Hee Han,"Microneedle drug delivery
www.wjpps.com │ Vol 9, Issue 11, 2020. │ ISO 9001:2015 Certified Journal │
2668
Patel et al. World Journal of Pharmacy and Pharmaceutical Sciences
system including movable drug conatining capsule ", United States Patent Application
Publication, Pub. No.: US 2011/0046557.
12. Junjie Chi, Xiaoxuan Zhang, Canwen Chen, Changmin Shao, Yuanjin Zhao, Yongan
Wang," Antibacterial and angiogenic chitosan microneedle array patch for promoting
wound healing ",KeAi Communications Co., Ltd, 2020; 253-259.
doi.org/10.1016/j.bioactmat.2020.02.004.
13. Kasturi r. pawar, Forrest smith, Chandra Sekhar Kolli, R. jaychandra babu ,"Effect of
Lipophilicity on Microneedle-Mediated Iontophoretic Transdermal Delivery Across
Human Skin In Vitro", Pharmaceutics, Drug Delivery and Pharmaceutical Technology,
2013; 3784-3791. DOI 10.1002/jps.23694.
14. Xiaoxuan Zhang, Guopu Chen, Yunru Yu, Lingyu Sun, and Yuanjin Zhao, " Bioinspired
Adhesive and Antibacterial Microneedles for Versatile Transdermal Drug Delivery",
Research a science paper journal, doi.org/10.34133/2020/3672120.
15. Ogundele, M., and H. K. Okafor. “Transdermal Drug Delivery: Microneedles, Their
Fabrication and Current Trends in Delivery Methods”. Journal of Pharmaceutical
Research International, 2017; 18(5): 1-14, DOI:10.9734/JPRI/2017/36164.
16. Kyung Ju Lee, Seong Sik Jeong, Dong Hyun Roh, Dong Yeong Kim, Hoo-Kyun Choi,
Eun Hee Lee, "A practical guide to the development of microneedle systems In clinical
trials or on the market", International Journal of Pharmaceutics,
doi.org/10.1016/j.ijpharm.2019.118778 2019.
17. Rezvan Jamaledin, Concetta Di Natale, Valentina Onesto, Zahra Baghban Taraghdari,
Ehsan Nazarzadeh Zare, Pooyan Makvandi, Raaele Vecchione, and Paolo Antonio Netti,
" Progress in Microneedle-Mediated Protein Delivery", Clin. Med, 2020; 9: 542. doi:
10.3390/jcm9020542.
18. Niclas Roxhed,"A Fully Integrated Microneedle-based Transdermal Drug Delivery
System", 2007; ISSN 1653-5146.
19. Desale Rohan S, Wagh Kalpesh S, Akarte Anup M, Baviskar Dheeraj T, Jain Dinesh K,
"Microneedle Technology for Advanced Drug Delivery: A review". International Journal
of Pharma Tech Research, 2012; 4(1): 181-189. ISSN: 0974-4304.
20. Nahid Tabassum, Aasim Sofi, Tahir Khuroo,"Microneedle Technology: A New Drug
Delivery System", Internatioal Journal of Research in Pharmaceutical and Biomedical
Sciences, 2011; 2(1): ISSN: 2229-3701.
21. Trimmer W, Ling P, Chin CK, Orten P, Gaugler R, Hashmi S, Hashmi G and Bruunett B.
Injection of DNA into plant and animl tissues with micromechanical piecing structures.
www.wjpps.com │ Vol 9, Issue 11, 2020. │ ISO 9001:2015 Certified Journal │
2669
Patel et al. World Journal of Pharmacy and Pharmaceutical Sciences
In: Proceedings of the IEEE Microelectromechancal Systems Workshop Amsterdam,
1995; 8: 111-115.
22. Jae-Ho Oh, Hyoun-Hyang Park, Ki-Young Do, Manhee Han, Dong-Hun Hyun,Chang-
Gyu Kim, Chang-Hyeon Kim, Seung S. Lee, Sung-Joo Hwang, Sang-Chul Shin, Cheong-
Weon Cho," Influence of the delivery systems using a microneedle array on the
permeation of a hydrophilic molecule, calcein",European Journal of Pharmaceutics and
Biopharmaceutics, 2008; 69: 1040-1045. doi:10.1016/j.ejpb.2008.02.009.
23. Wilke N, Mulcahy A, Ye SR, Morrissey A. Process Optimization and Characterization of
Silicon Microneedles Fabricated by Wet Etch Technology. Microelectronics Journal,
2005; 36: 650-656.
24. Chanda Silpi, Bagga Manish, Tiwari Raj,"Microneedles in Transdermal Drug Delivery :
an unique Painless Option", International Research Journal Of Pharmacy, 2011; 2(4):
72-78. ISSN: 2230-8407.
25. Microneedles gives painless shot. Proceedings: National Academy of Sciences, 2003.
Available
from:http://www.trnmag.com/Stories/2003/120303/Microneedles_give_painless_shots_B
rief_120303.html.
26. Wilke N, Mulcahy A, Ye SR, Morrissey A. Process Optimization and Characterization of
Silicon Microneedles Fabricated by Wet Etch Technology. Microelectronics Journal,
2005; 36: 650-656.
27. Microneedles: Report Describes Progress in Developing New Technology for Painless
Drug and Vaccine Delivery, Georgia Research Tech News, 2003.
28. Barry B. Transdermal drug delivery. Churchill Livingstone, Newyork: Harcourt
publishers, 2002; 2.
29. Devender M. Sharma,"Microneedles: an approach in transdermal drug delivery: a
Review", Phama Tutor, 2018; 6(1): -8, DOI:10.29161/PT.v6.i1.2017.7.
30. Frid, A.H., Kreugel, G., Grassi, G., Halimi, S., Hicks, D., Hirsch, L.J., Smith,
M.J.,Wellhoener, R., Bode, B.W., Hirsch, I.B., Kalra, S., Ji, L., Strauss, K.W., New
Insulin Delivery Recommendations. Mayo Clin. Proc, 2016; 91, 1231–1255. https://doi.
org/10.1016/j.mayocp.2016.06.010.
31. Antonio José Guillot, Ana Sara Cordeiro, Ryan F. Donnelly, M. Carmen
Montesinos,Teresa M. Garrigues, and Ana Melero, "Microneedle Based Delivery: An
Overview of Current Applications and Trends", MDPI,
doi:10.3390/pharmaceutics12060569.
www.wjpps.com │ Vol 9, Issue 11, 2020. │ ISO 9001:2015 Certified Journal │
2670
Patel et al. World Journal of Pharmacy and Pharmaceutical Sciences
32. Sternberg, F., Meyerhoff, C., Mennel, F.J., Mayer, H., Bischof, F., Pfeiffer, E.F., Does
fall in tissue glucose precede fall in blood glucose? Diabetologia, 1996; 39: 609–612.
doi.org/10.1007/bf00403309.
33. Kai Chen, Min Pan and Zhi-Gang Feng, "Modeling of Drug Delivery by A Pump Driven
Micro-Needle Array System", The Open Biomedical Engineering Journal, 2016; 10:
19-33. DOI: 10.2174/1874120701610010019.
34. Nolan LMA, Corish J, Corrigan OI, Fitzpatrick D. Iontophoretic and chemical
enhancement of drug delivery: Part-I: Across Artificial Membranes. Int J Pharm, 2003;
257: 41-55.
35. Park J.H., Allen M.G., Prausnitz M.R., "Biodegradable polymer microneedles
Fabrication, mechanics and transdermal drug delivery", Journal of Controlled Release,
Stanleyand W, 2005; 104(1): 51–66. 20.
36. S. Hashmi, P. Ling, G. Hashmi, M. Reed, R. Gaugler, W. Trimmer, Genetic
transformation of nematodes using arrays of micromechanical piercing structures,
BioTechniques, 1995; 19: 766 – 770.
37. Saroha K, Nanda S, Rani S. Chemical penetration enhances: a novel approach in
transdermal drug delivery system. Int J Curr Pharm Res, 2011; 3(4): 5-9.
38. Nolan LMA, Corish J, Corrigan OI, Fitzpatrick D. Iontophoretic and chemical
enhancement of drug delivery: Part-I: Across Artificial Membranes. Int J Pharm, 2003;
257: 41-55.
39. Kumar AV, Kulkarni PR, Raut RA. Microneedles: promising technique for transdermal
drug delivery. Int J Pharm Bio Sci, 2011; 2(1): 684-708.
40. Micropiles.http://www.texmac.com/.../7-12- 2004_Press_Release.html.
41. Shital H. Bariya , Mukesh C. Gohel , Tejal A. Mehta and Om Prakash Sharma,"
Microneedles: an emerging transdermal drug delivery system" , Journal of Pharmacy And
Pharmacology, 2011. Doi: 10.1111/j.2042-7158.2011.01369.x.
42. Smart miniature drug delivery systems, Dolcera. http://www.dolcera.
com/wiki/index.php?title=Smart_ miniature_drug_delivery_systems (accessed 9 July
2011).
43. Lhernould, M.S.; and Delchambre, A. Innovative design of hollow polymeric
microneedles for transdermal drug delivery. Microsystem Technology, 2011; 17(10):
1675-1682.
44. Liliana R Pires, KB Vinayakumar, Maria Turos, Verónica Miguel and João Gaspar,"A
Perspective on Microneedle-Based Drug Delivery and Diagnostics in Paediatrics", Med,
www.wjpps.com │ Vol 9, Issue 11, 2020. │ ISO 9001:2015 Certified Journal │
2671
Patel et al. World Journal of Pharmacy and Pharmaceutical Sciences
2019; 9: 49; doi:10.3390/jpm9040049.
45. Jeong Woo Lee & Mark R. Prausnitz ."Drug delivery using microneedle patches: not just
for skin". Expert Opinion on Drug Delivery, 15(6): 541-543, ISSN: 1742-5247
DOI:10.1080/17425247.2018.1471059.
46. Donald J, Kellerman MA, Tepper SJ. Rapid systemic delivery of zolmitriptan using an
adhesive dermally applied microarray. Pain Management, 2017; 7(6): 559–567.
47. Dhurat R, Sukesh M, Avhad G, et al. A randomized evaluator blinded study of effect of
microneedling in androgenetic alopecia: a pilot study. Int J Trichology, 2013; 5(1).
48. Xiaoxuan Zhang, Guopu Chen, Yunru Yu, Lingyu Sun, and Yuanjin Zhao, " Bioinspired
Adhesive and Antibacterial Microneedles for Versatile Transdermal Drug Delivery",
Research a science paper journal, doi.org/10.34133/2020/3672120, pp. 3-4.
49. Vadim V. Yuzhakov, "The AdminPenTM Microneedle Device for Painless & Convenient
Drug Delivery", Drug Delivery Technology, 2010.
50. Ebtisam Elghblawi, "Medical Micro-Needling",Trichol Cosmetol Open J, 21-24.
doi.org/10.17140/TCOJ-1-105,
51. Singh A, Yadav S. Microneedling: Advances and widening horizons. Indian Dermatol
Online J, 2016; 7(4): 244-254. doi: 10.4103/2229-5178.185468.
52. Serrano G, Almudéver P, Serrano JM, et al. Microneedling di_lates the follicular
infundibulum and increases transfollicular absorption of liposomal sepia melanin. Clin
Cosmet Investig Dermatol, 2015; 8: 313-318. doi: 10.2147/CCID.S77228.
53. Johannes Hackethal, Fredrik Iredahl, Joakim Henricson, Chris D. Anderson, Erik
Tesselaar,"Microvascular effects of microneedles application ", Research gate, 2020;
1-12. DOI: 10.1111/srt.12918.
54. Jitu Halder, Sudhanshu Gupta, Rakhi Kumari, Ghanshyam Das Gupta,Vineet Kumar
Rai," Microneedle Array: Applications, Recent Advances, and Clinical Pertinence in
Transdermal Drug Delivery",Journal of Pharmaceutical Innovation ,
Doi.org/10.1007/s12247-020-09460.
55. L. Lu, C. A. Garcia, and A. G. Mikos. In vitro degradation of thin poly (DL-lactic-co-
glycolic acid) fifilms. J. Biomed. Mater. Res, 1999; 46: 236Y244.
56. Saroha K, Nanda S, Rani S. Chemical penetration enhances: a novel approach in
transdermal drug delivery system. Int J Curr Pharm Res, 2011; 3(4): 5-9.
57. Cai B, Xia W, Bredenberg S, Li H, Engqvist H. Bioceramic microneedles with flexible
and self-swelling substrate. Eur J Pharm Biopharm, 2015; 94: 404-410.
58. Ryan F. Donnelly, Thakur Raghu Raj Singh, and A. David Woolfson, "Microneedles:
www.wjpps.com │ Vol 9, Issue 11, 2020. │ ISO 9001:2015 Certified Journal │
2672
Patel et al. World Journal of Pharmacy and Pharmaceutical Sciences
design, micro fabrication, optimization", informahealthcare, 2010. DOI:
10.3109/10717541003667798, ISSN 1071-7544
59. Eman M. Migdadi, Aaron J. Courtenay, Ismaiel A. Tekko, Maelíosa T.C. McCrudden,
Mary-Carmel Kearney, Emma McAlister, Helen O. McCarthy, Ryan F.
Donnelly,"Hydrogel-forming microneedles enhance transdermal delivery of metformin
hydrochloride", Elsevier, 2018. doi.org/10.1016/j.jconrel.2018.07.009
60. Nayak Smita, Suryawanshi Sanidhya, Vaidhun Bhaskar," MICRONEEDLE
TECHNOLOGY FOR TRANSDERMAL DRUG DELIVERY: APPLICATIONS AND
COMBINATION WITH OTHER ENHANCING TECHNIQUES", Journal of Drug
Delivery & Therapeutics, 2016; 6(5): 65-83, doi.org/10.22270/jddt.v6i5.1285.
61. Caffffarel-Salvador, E.; Tuan-Mahmood, T.M.; McElnay, J.C.; McCarthy, H.O.; Mooney,
K.; Woolfson, A.D.;Donnelly, R.F. Potential of hydrogel-forming and dissolving
microneedles for use in paediatric populations. Int. J. Pharm, 2015; 489: 158–169.
62. Duarah, S.; Sharma, M.; Wen, J.Y. Recent advances in microneedle-based drug delivery:
Special emphasis on its use in paediatric population. Eur. J. Pharm. Biopharm, 2019;
136: 48–69.
63. Eun Kima, Geza Erdos, Shaohua Huang, Thomas W. Kenniston, Stephen C. Balmert,
Cara Donahue Carey, V. Stalin Raj, Michael W. Epperly, William B. Klimstra, Bart L.
Haagmans, Emrullah Korkmaz, Louis D. Falo Jr, Andrea Gambotto,"Microneedle array
delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational
development", Elsevier, 2020. Doi.org/10.1016/j.ebiom.2020.102743.
64. Mark R. Prausnitz," Microneedles for transdermal drug delivery", Science direct, 2003.
doi:10.1016/j.addr.2003.10.023.
65. Donnelly RF, Singh TRR, Woolfson AD. Microneedle-based drug delivery systems:
Microfabrication, drug delivery, and safety. Drug Deliv, 2010; 17(4): 187–207.